MIRM
Mirum Pharmaceuticals Inc
Price:  
45.24 
USD
Volume:  
1,249,638.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MIRM WACC - Weighted Average Cost of Capital

The WACC of Mirum Pharmaceuticals Inc (MIRM) is 8.3%.

The Cost of Equity of Mirum Pharmaceuticals Inc (MIRM) is 8.55%.
The Cost of Debt of Mirum Pharmaceuticals Inc (MIRM) is 7.00%.

Range Selected
Cost of equity 7.00% - 10.10% 8.55%
Tax rate 0.40% - 0.80% 0.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.0% - 9.7% 8.3%
WACC

MIRM WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.68 0.93
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 10.10%
Tax rate 0.40% 0.80%
Debt/Equity ratio 0.14 0.14
Cost of debt 7.00% 7.00%
After-tax WACC 7.0% 9.7%
Selected WACC 8.3%

MIRM's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for MIRM:

cost_of_equity (8.55%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.68) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.